MEHAOTCMedicinal Chemicals & Botanical ProductsUS GAAP · USD

Functional Brands Inc.

Functional Brands Inc. manufactures and distributes over-the-counter nutraceutical supplements in a range of wellness categories, including pain, energy, prenatal, immunity, sleep, and digestive health. The company sells primarily to end consumers through pharmacies, U.S. wholesalers, international distributors, and direct-to-consumer channels.

Kysy yhtiöstä
Liikevaihto6,6milj. USD
+0,7 %v/v
Liikevoitto (EBIT)−1,4milj. USD
−510,5 %v/v
EBIT-marginaali−21,2%
−17,7 %-yks.v/v
Nettotulos0,8milj. USD
+235,6 %v/v
Vapaa kassavirta−1,3milj. USD
−1 174 464,2 %v/v

Tilikausi 2025 · muutos edellisvuodesta

Kehitys 2024–2025

−202468milj. USD2024: 6,6 milj. USD2024: EBIT −0,23 milj. USD20242025: 6,6 milj. USD2025: EBIT −1,4 milj. USD20256,6−1,4
LiikevaihtoLiikevoitto (EBIT)
Kysy Clarifolta: Functional Brands Inc.

Liiketoiminta

Osuus liikevaihdosta
Core nutraceutical supplements100 %

OTC supplement products sold across wellness and preventive health categories.

Tuotteet

Raportoitu · osuus liikevaihdosta
98,1%FY2025100 %
  • Nutraceuticalsupplements98,1 %
  • Hemp Derived Products1,9 %

Lähde: 10-K FY2025, yhtiön tuotelinjoittain raportoima liikevaihto (SEC XBRL). Osuudet on laskettu näytetyistä riveistä ja ne summautuvat 100 %:iin.

Asiakkaat

The company serves end consumers who buy supplements for everyday wellness, symptom relief, and preventive health support. Demand flows through pharmacies, U.S. wholesalers, international distributors, and direct-to-consumer channels, so the customer base includes both retail buyers and channel partners that resell to consumers.

End consumers

Buy OTC supplements for pain, sleep, immunity, energy, and general wellness.

Pharmacies

Purchase products for retail shelves and repeat consumer demand.

U.S. wholesalers

Buy in bulk to distribute products into downstream retail channels.

International distributors

Import and resell supplements in non-U.S. markets.

Direct-to-consumer shoppers

Purchase online, supporting growth in the company's DTC channel.

Strategia

Management is focused on growing revenue through direct-to-consumer demand while maintaining distribution through pharmacies, wholesalers, and international partners. The company also appears to be tightening cost controls and negotiating better vendor terms, which supports gross margin improvement in a small-scale consumer health business.

Grow direct-to-consumer salesLyhyt aikaväli

The 10-Q says revenue growth was primarily driven by DTC demand, making this the clearest growth lever.

Strengthen channel mixKeskipitkä aikaväli

Selling through pharmacies, wholesalers, and distributors reduces reliance on one route to market.

Improve margin disciplineLyhyt aikaväli

A small revenue base makes cost control and vendor terms important to operating leverage.

Maantiede

The company is based in the United States and appears to operate primarily from the U.S. market, with additional sales through international distributors. The filings do not disclose a country-by-country revenue split, so the geographic profile should be viewed as U.S.-centric with some export exposure rather than a fully diversified global footprint.

Riskit

Functional Brands faces the typical risks of a small consumer health and supplement business: demand volatility, marketing dependence, and inventory obsolescence. The filing also highlights judgment-heavy accounting areas such as goodwill, long-lived assets, and provisions, which can create earnings volatility if assumptions weaken or assets underperform.

Järjestetty vakavuuden mukaan
Goodwill and long-lived asset impairmentKorkea

Management explicitly cites recoverability of goodwill and long-lived assets as critical estimates.

KohdistuuPropertyEquipmentIntangible assets could be impaired if cash flows weaken
Demand and channel concentrationKorkea

Revenue growth was primarily driven by direct-to-consumer demand, making the business sensitive to channel performance.

Kohdistuu: DTC and consumer wellness demand

Inventory obsolescenceKeskitaso

Supplements have shelf-life and demand uncertainty, so excess or aged inventory may need write-downs.

KohdistuuInventory reserve increased to $77722 at Sep. 302025
Financing and interest expenseKeskitaso

Interest expense increased materially in the quarter and nine-month period, indicating financing cost sensitivity.

Kohdistuu: Convertible debenture and other financing instruments

Kysy Clarifolta: Functional Brands Inc.

Kirjanpito

Harkinnanvaraiset erät
Inventory obsolescence reserve

Management estimates write-downs based on demand, shelf life, and aged stock.

Vaikutus: Directly affects cost of goods sold and gross margin

Goodwill and long-lived asset impairment

Recoverability depends on future cash flow assumptions and fair value estimates.

Vaikutus: Can create material non-cash charges

Fair value of convertible debentures and warrants

Equity-linked financing instruments require valuation analysis and can move earnings.

Vaikutus: Affects other income/expense and balance-sheet carrying values

Lease accounting

Discount rate assumptions affect right-of-use assets and lease liabilities.

Vaikutus: Impacts leverage metrics and depreciation/interest split

Provisions and contingencies

Management must estimate uncertain obligations and potential claims.

Vaikutus: Can affect liabilities and period expense

Samankaltaisia listattuja yhtiöitä

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Sentient Brands Holdings Inc.

SNBH · Retail-Computer & Computer Software Stores

FitLife Brands, Inc

FTLF · Medicinal Chemicals & Botanical Products

International Flavors & Fragrances, Inc

IFF · Industrial Organic Chemicals

Nature's Sunshine Products, Inc

NATR · Pharmaceutical Preparations

Fat Brands, Inc

FATAQ · Retail-Eating Places

Caring Brands, Inc.

CABR · Perfumes, Cosmetics & Other Toilet Preparations

Päivitetty: 24.9.2026

Functional Brands Inc. (OTC) – Medicinal Chemicals & Botanical Products | Analyysi – Clarifo